Of note, RHOC can promote cell cycle progression by upregulating cyclin D1 and CDK4 as well as downregulating cyclin-dependent kinase inhibitors, p16 and p21, thus promoting HCC cell proliferation [121]. Here, RHOC is linked to hepatocellular carcinoma.